Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA decision on generic Premarin

May 8, 1997

Kissei licenses antidiabetic agent to Purdue

May 8, 1997

Genentech enters into agreement for embryonic stem cell renewal factor

May 8, 1997

Senetek seeks European approval of erectile dysfunction therapy

May 8, 1997

DEA recommends descheduling of Redux

May 7, 1997

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

Gene Logic and Johns Hopkins University enter into research collaboration

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

Positive clinical results for amylin analogue in diabetes

May 7, 1997

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...